XML 17 R7.htm IDEA: XBRL DOCUMENT v3.25.3
Consolidated Statements of Equity - USD ($)
$ in Thousands
Total
Total Bentley Systems Stockholders' Equity
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Non-Controlling Interest
Beginning balance (in shares) at Dec. 31, 2023     296,265,837        
Beginning balance at Dec. 31, 2023 $ 883,982 $ 883,278 $ 2,963 $ 1,127,234 $ (84,987) $ (161,932) $ 704
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) 184,694 184,694       184,694  
Other comprehensive (loss) income 2,028 2,028     2,028    
Dividends declared (53,985) (53,985)       (53,985)  
Shares issued in connection with deferred compensation plan, net (in shares)     4,655,277        
Shares issued in connection with deferred compensation plan, net 0 0 $ 46 (46)      
Deferred compensation plan elective participant deferrals 144 144   144      
Shares issued in connection with executive bonus plan, net (in shares)     256,587        
Shares issued in connection with executive bonus plan, net 13,199 13,199 $ 3 13,196      
Shares issued in connection with employee stock purchase plan, net (in shares)     253,578        
Shares issued in connection with employee stock purchase plan, net 10,880 10,880 $ 2 11,226   (348)  
Stock option exercises, net (in shares)     844,283        
Stock option exercises, net 1,812 1,812 $ 8 3,999   (2,195)  
Shares issued for stock grants, net (in shares)     11,391        
Shares issued for stock grants, net 600 600   600      
Stock-based compensation expense 45,096 45,096   45,096      
Shares related to restricted stock, net (in shares)     668,586        
Shares related to restricted stock, net (8,671) (8,671) $ 7 (7)   (8,671)  
Repurchases of Class B common stock under approved program (in shares)     (912,737)        
Repurchases of Class B common stock under approved program (45,769) (45,769) $ (9)     (45,760)  
Ending balance (in shares) at Sep. 30, 2024     302,042,802        
Ending balance at Sep. 30, 2024 1,034,010 1,033,306 $ 3,020 1,201,442 (82,959) (88,197) 704
Beginning balance (in shares) at Jun. 30, 2024     299,747,133        
Beginning balance at Jun. 30, 2024 984,506 983,802 $ 2,997 1,176,630 (93,264) (102,561) 704
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) 42,338 42,338       42,338  
Other comprehensive (loss) income 10,305 10,305     10,305    
Dividends declared (18,134) (18,134)       (18,134)  
Shares issued in connection with deferred compensation plan, net (in shares)     2,181,214        
Shares issued in connection with deferred compensation plan, net 0 0 $ 22 (22)      
Deferred compensation plan elective participant deferrals 43 43   43      
Shares issued in connection with executive bonus plan, net (in shares)     88,296        
Shares issued in connection with executive bonus plan, net 4,283 4,283 $ 1 4,282      
Shares issued in connection with employee stock purchase plan, net (in shares)     131,558        
Shares issued in connection with employee stock purchase plan, net 5,495 5,495 $ 1 5,667   (173)  
Stock-based compensation expense 14,843 14,843   14,843      
Shares related to restricted stock, net (in shares)     77,657        
Shares related to restricted stock, net (1,415) (1,415) $ 1 (1)   (1,415)  
Repurchases of Class B common stock under approved program (in shares)     (183,056)        
Repurchases of Class B common stock under approved program (8,254) (8,254) $ (2)     (8,252)  
Ending balance (in shares) at Sep. 30, 2024     302,042,802        
Ending balance at Sep. 30, 2024 1,034,010 1,033,306 $ 3,020 1,201,442 (82,959) (88,197) 704
Beginning balance (in shares) at Dec. 31, 2024     301,977,330        
Beginning balance at Dec. 31, 2024 1,041,120 1,040,987 $ 3,020 1,217,986 (104,078) (75,941) 133
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) 219,127 219,223       219,223 (96)
Other comprehensive (loss) income 26,643 26,633     26,633   10
Dividends declared (63,756) (63,756)       (63,756)  
Shares issued in connection with deferred compensation plan, net (in shares)     1,635,396        
Shares issued in connection with deferred compensation plan, net (13,558) (13,558) $ 16 (16)   (13,558)  
Shares issued in connection with executive bonus plan, net (in shares)     66,837        
Shares issued in connection with executive bonus plan, net 3,232 3,232 $ 1 4,917   (1,686)  
Shares issued in connection with employee stock purchase plan, net (in shares)     280,767        
Shares issued in connection with employee stock purchase plan, net 10,995 10,995 $ 3 11,531   (539)  
Shares issued for stock grants, net (in shares)     12,591        
Shares issued for stock grants, net 600 600   600      
Stock-based compensation expense 48,575 48,575   48,575      
Shares related to restricted stock, net (in shares)     942,439        
Shares related to restricted stock, net (12,599) (12,599) $ 9 (9)   (12,599)  
Repurchases of Class B common stock under approved program (in shares)     (1,457,454)        
Repurchases of Class B common stock under approved program (65,029) (65,029) $ (15)     (65,014)  
Ending balance (in shares) at Sep. 30, 2025     303,457,906        
Ending balance at Sep. 30, 2025 1,195,350 1,195,303 $ 3,034 1,283,584 (77,445) (13,870) 47
Beginning balance (in shares) at Jun. 30, 2025     303,438,072        
Beginning balance at Jun. 30, 2025 1,162,170 1,162,041 $ 3,034 1,259,476 (69,095) (31,374) 129
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) 57,289 57,373       57,373 (84)
Other comprehensive (loss) income (8,348) (8,350)     (8,350)   2
Dividends declared (21,263) (21,263)       (21,263)  
Shares issued in connection with deferred compensation plan, net (in shares)     62,567        
Shares issued in connection with deferred compensation plan, net (2,393) (2,393)       (2,393)  
Shares issued in connection with executive bonus plan, net (in shares)     17,292        
Shares issued in connection with executive bonus plan, net 1,010 1,010 $ 1 1,793   (784)  
Shares issued in connection with employee stock purchase plan, net (in shares)     150,555        
Shares issued in connection with employee stock purchase plan, net 5,852 5,852 $ 2 6,220   (370)  
Stock-based compensation expense 16,095 16,095   16,095      
Shares related to restricted stock, net (in shares)     73,833        
Shares related to restricted stock, net (56) (56)       (56)  
Repurchases of Class B common stock under approved program (in shares)     (284,413)        
Repurchases of Class B common stock under approved program (15,006) (15,006) $ (3)     (15,003)  
Ending balance (in shares) at Sep. 30, 2025     303,457,906        
Ending balance at Sep. 30, 2025 $ 1,195,350 $ 1,195,303 $ 3,034 $ 1,283,584 $ (77,445) $ (13,870) $ 47